The combination of Avastin (Bevacizumab) and chemotherapy offers improved tumour control, progression-free survival, and quality of life. However, it carries risks such as high blood pressure, bleeding, and intensified chemotherapy side effects. Patients should work closely with healthcare providers to monitor these risks.